{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T18:25:50Z","timestamp":1758479150948},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T00:00:00Z","timestamp":1465257600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s00705-016-2916-6","type":"journal-article","created":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T05:52:02Z","timestamp":1465278722000},"page":"2537-2541","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Rabies vaccination at a virus-inoculated site as an alternative option to rabies immunoglobulin"],"prefix":"10.1007","volume":"161","author":[{"given":"Kinjiro","family":"Morimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pakamatz","family":"Khawplod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phatthamon","family":"Virojanapirom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiravat","family":"Hemachudha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,7]]},"reference":[{"key":"2916_CR1","unstructured":"World Health Organization (Geneva) (2013) WHO expert consultation on rabies. WHO Technical Report Series 982"},{"issue":"11","key":"2916_CR2","doi-asserted-by":"publisher","first-page":"e542","DOI":"10.1371\/journal.pntd.0000542","volume":"3","author":"T M\u00fcller","year":"2009","unstructured":"M\u00fcller T, Dietzschold B, Ertl H, Fooks AR, Freuling C, Fehlner-Gardiner C, Kliemt J, Meslin FX, Franka R, Rupprecht CE, Tordo N, Wanderler AI, Kieny MP (2009) Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans. PLoS Negl Trop Dis 3(11):e542. doi: 10.1371\/journal.pntd.0000542","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"2916_CR3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1708-8305.1999.tb00525.x","volume":"6","author":"H Wilde","year":"1999","unstructured":"Wilde H, Tipkong P, Khawplod P (1999) Economic issue in post-exposure rabies treatment. J Travel Med 6(4):238\u2013242","journal-title":"J Travel Med"},{"issue":"2","key":"2916_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.vaccine.2015.11.036","volume":"34","author":"H Wilde","year":"2015","unstructured":"Wilde H, Lumlertdacha B, Meslin FX, Ghai S, Hemachudha T (2015) Worldwide rabies deaths prevention-A focus on the current inadequacies in postexposure prophylaxis of animal bite victims. Vaccine 34(2):187\u2013189. doi: 10.1016\/j.vaccine.2015.11.036","journal-title":"Vaccine"},{"issue":"8694","key":"2916_CR5","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/0140-6736(90)90488-Q","volume":"335","author":"S Chutivongse","year":"1990","unstructured":"Chutivongse S, Wilde H, Supich C, Baer GM, Fishbein DB (1990) Postexposure prophylaxis for rabies with antiserum and intradermal vaccination. Lancet 335(8694):896\u2013898","journal-title":"Lancet"},{"issue":"29","key":"2916_CR6","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1016\/j.vaccine.2010.04.090","volume":"28","author":"A Saraya","year":"2010","unstructured":"Saraya A, Wacharapluesadee S, Khawplod P, Tepsumethanon S, Briggs D, Asawavichienjinda T, Hemachudha T (2010) A preliminary study of chemo- and cytokine responses in rabies vaccine recipients of intradermal and intramuscular regimens. Vaccine 28(29):4553\u20134557","journal-title":"Vaccine"},{"issue":"11","key":"2916_CR7","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1007\/s00705-012-1402-z","volume":"157","author":"P Virojanapirom","year":"2012","unstructured":"Virojanapirom P, Khawplod P, Sawangvaree A, Wacharapluesadee S, Hemachudha T, Yamada K, Morimoto K, Nishizono A (2012) Molecular analysis of the mutational effects of Thai street rabies virus with increased virulence in mice after passages in the BHK cell line. Arch Virol 157(11):2201\u20132205. doi: 10.1007\/s00705-012-1402-z","journal-title":"Arch Virol"},{"key":"2916_CR8","first-page":"181","volume-title":"Laboratory techniques in rabies","author":"JS Smith","year":"1996","unstructured":"Smith JS, Yager PA, Baer GM (1996) A rapid fluorescent focus inhibition test (RFFIT) for determining rabies virus-neutralising antibody. In: Meslin FX, Kaplan MM, Koprowski H (eds) Laboratory techniques in rabies, 4th edn. World Health Organization, Geneva, pp 181\u2013192","edition":"4"},{"issue":"5","key":"2916_CR9","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1086\/514737","volume":"28","author":"T Tantawichien","year":"1999","unstructured":"Tantawichien T, Benjavongkulchai M, Limsuwan K, Khawplod P, Kaewchompoo W, Chomchey P, Sitprija V (1999) Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine. Clin Infect Dis 28(5):1100\u20131103","journal-title":"Clin Infect Dis"},{"key":"2916_CR10","unstructured":"World Health Organization (Geneva) Rabies vaccines WHO position paper (2007) Weekly Epidemiological Record No.\u00a049\/50, pp 425\u2013436"},{"issue":"6","key":"2916_CR11","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/13550280500385310","volume":"11","author":"L Sarmento","year":"2005","unstructured":"Sarmento L, Li XQ, Howerth E, Jackson AC, Fu ZF (2005) Glycoprotein-mediated induction of apoptosis limits the spread of attenuated rabies viruses in the central nervous system of mice. J Neurovirol 11(6):571\u2013581","journal-title":"J Neurovirol"},{"issue":"3","key":"2916_CR12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.vaccine.2007.10.072","volume":"26","author":"J Li","year":"2008","unstructured":"Li J, McGettigan JP, Faber M, Schnell MJ, Dietzschold B (2008) Infection of monocytes or immature dendritic cells (DCs) with an attenuated rabies virus results in DC maturation and a strong activation of the NF\u03baB signaling pathway. Vaccine 26(3):419\u2013426","journal-title":"Vaccine"},{"issue":"1\u20132","key":"2916_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.virusres.2009.03.014","volume":"144","author":"Y Kuang","year":"2009","unstructured":"Kuang Y, Lackay SN, Zhao L, Fu ZF (2009) Role of chemokines in the enhancement of BBB permeability and inflammatory infiltration after rabies virus infection. Virus Res 144(1\u20132):18\u201326. doi: 10.1016\/j.virusres.2009.03.014","journal-title":"Virus Res"},{"key":"2916_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/B978-0-12-387040-7.00003-2","volume":"79","author":"M Lafon","year":"2011","unstructured":"Lafon M (2011) Evasive strategies in rabies virus infection. Adv Virus Res 79:33\u201353. doi: 10.1016\/B978-0-12-387040-7.00003-2","journal-title":"Adv Virus Res"},{"issue":"2","key":"2916_CR15","doi-asserted-by":"publisher","first-page":"e1000315","DOI":"10.1371\/journal.ppat.1000315","volume":"5","author":"P Menager","year":"2009","unstructured":"Menager P, Roux P, Megret F, Bourgeois JP, Le Sourd AM, Danckaert A, Lafage M, Prehaud C, Lafon M (2009) Toll-like receptor 3 (TLR3) plays a major role in the formation of rabies virus Negri Bodies. PLoS Pathog 5(2):e1000315. doi: 10.1371\/journal.ppat.1000315","journal-title":"PLoS Pathog"},{"issue":"12","key":"2916_CR16","doi-asserted-by":"publisher","first-page":"7673","DOI":"10.1128\/JVI.79.12.7673-7681.2005","volume":"79","author":"K Brzozka","year":"2005","unstructured":"Brzozka K, Finke S, Conzelmann KK (2005) Identification of the rabies virus alpha\/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J Virol 79(12):7673\u20137681. doi: 10.1128\/JVI.79.12.7673-7681.2005","journal-title":"J Virol"},{"issue":"6","key":"2916_CR17","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1128\/JVI.80.6.2675-2683.2006","volume":"80","author":"K Brzozka","year":"2006","unstructured":"Brzozka K, Finke S, Conzelmann KK (2006) Inhibition of interferon signaling by rabies virus phosphoprotein P: activation-dependent binding of STAT1 and STAT2. J Virol 80(6):2675\u20132683. doi: 10.1128\/JVI.80.6.2675-2683.2006","journal-title":"J Virol"},{"key":"2916_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/B978-0-12-387040-7.00006-8","volume":"79","author":"M Rieder","year":"2011","unstructured":"Rieder M, Conzelmann KK (2011) Interferon in rabies virus infection. Adv Virus Res 79:91\u2013114. doi: 10.1016\/B978-0-12-387040-7.00006-8","journal-title":"Adv Virus Res"},{"issue":"22","key":"2916_CR19","doi-asserted-by":"publisher","first-page":"14411","DOI":"10.1128\/JVI.79.22.14411-14420.2005","volume":"79","author":"A Vidy","year":"2005","unstructured":"Vidy A, Chelbi-Alix M, Blondel D (2005) Rabies virus P protein interacts with STAT1 and inhibits interferon signal transduction pathways. J Virol 79(22):14411\u201314420. doi: 10.1128\/JVI.79.22.14411-14420.2005","journal-title":"J Virol"},{"issue":"8","key":"2916_CR20","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1128\/JVI.01930-06","volume":"81","author":"A Vidy","year":"2007","unstructured":"Vidy A, El Bougrini J, Chelbi-Alix MK, Blondel D (2007) The nucleocytoplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1. J Virol 81(8):4255\u20134263. doi: 10.1128\/JVI.01930-06","journal-title":"J Virol"},{"key":"2916_CR21","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1242\/jcs.045542","volume":"122","author":"GW Moseley","year":"2009","unstructured":"Moseley GW, Lahaye X, Roth DM, Oksayan S, Filmer RP, Rowe CL, Blondel D, Jans DA (2009) Dual modes of rabies P-protein association with microtubules: a novel strategy to suppress the antiviral response. J Cell Sci 122:3652\u20133662. doi: 10.1242\/jcs.045542","journal-title":"J Cell Sci"},{"issue":"13","key":"2916_CR22","doi-asserted-by":"publisher","first-page":"6657","DOI":"10.1128\/JVI.00302-11","volume":"85","author":"D Chopy","year":"2011","unstructured":"Chopy D, Pothlichet J, Lafage M, Megret F, Fiette L, Si-Tahar M, Lafon M (2011) Ambivalent role of the innate immune response in rabies virus pathogenesis. J Virol 85(13):6657\u20136668. doi: 10.1128\/JVI.00302-11","journal-title":"J Virol"},{"issue":"1","key":"2916_CR23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4049\/jimmunol.121.1.321","volume":"121","author":"A Miller","year":"1978","unstructured":"Miller A, Morse HC 3rd, Winkelstein J, Nathanson N (1978) The role of antibody in recovery from experimental rabies. I. Effect of depletion of B and T cells. J Immunol 121(1):321\u2013326","journal-title":"J Immunol"},{"issue":"1","key":"2916_CR24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1128\/JVI.59.1.98-102.1986","volume":"59","author":"JW Templeton","year":"1986","unstructured":"Templeton JW, Holmberg C, Garber T, Sharp RM (1986) Genetic control of serum neutralizing-antibody response to rabies vaccination and survival after a rabies challenge infection in mice. J Virol 59(1):98\u2013102","journal-title":"J Virol"},{"issue":"2","key":"2916_CR25","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1006\/viro.1995.0049","volume":"214","author":"ZQ Xiang","year":"1995","unstructured":"Xiang ZQ, Knowles BB, McCarrick JW, Ertl HC (1995) Immune effector mechanisms required for protection to rabies virus. Virology 214(2):398\u2013404","journal-title":"Virology"},{"issue":"2","key":"2916_CR26","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0264-410X(03)00559-0","volume":"22","author":"A Servat","year":"2003","unstructured":"Servat A, Lutsch C, Delore V, Lang J, Veitch K, Cliquet F (2003) Efficacy of rabies immunoglobulins in an experimental post-exposure prophylaxis rodent model. Vaccine 22(2):244\u2013249","journal-title":"Vaccine"},{"issue":"3","key":"2916_CR27","doi-asserted-by":"publisher","first-page":"e2129","DOI":"10.1371\/journal.pntd.0002129","volume":"7","author":"CL Dorfmeier","year":"2013","unstructured":"Dorfmeier CL, Tzvetkov EP, Gatt A, McGettigan JP (2013) Investigating the role for IL-21 in rabies virus vaccine-induced immunity. PLoS Negl Trop Dis 7(3):e2129. doi: 10.1371\/journal.pntd.0002129","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"2916_CR28","doi-asserted-by":"publisher","first-page":"e63384","DOI":"10.1371\/journal.pone.0063384","volume":"8","author":"M Zhou","year":"2013","unstructured":"Zhou M, Zhang G, Ren G, Gnanadurai CW, Li Z, Chai Q, Yang Y, Leyson CM, Wu W, Cui M, Fu ZF (2013) Recombinant rabies viruses expressing GM-CSF or flagellin are effective vaccines for both intramuscular and oral immunizations. PLoS One 8(5):e63384. doi: 10.1371\/journal.pone.0063384","journal-title":"PLoS One"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-016-2916-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00705-016-2916-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-016-2916-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T11:34:38Z","timestamp":1718624078000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00705-016-2916-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,7]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["2916"],"URL":"https:\/\/doi.org\/10.1007\/s00705-016-2916-6","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,7]]}}}